0.50 / AMA PRA Category 1 CreditTM 0.50 / CE for Pharmacists (0.05 CEUs)
CME: Albert Einstein College of Medicine ACPE: University of Wisconsin-Madison Division of Pharmacy Professional Development
Supported by an educational grant from Janssen Therapeutics
Produced by Haymarket Medical Education
Access to medical care and effective medications is a key factor in reducing viral load and transmission rates among patients with HIV. Today, the more than 1.2 million Americans living with HIV/AIDS have greater access to quality treatment and care than ever before. Recent data suggest that enrolling low-income and underinsured people with HIV in one of the new healthcare plans available under the Affordable Care Act improves their likelihood of achieving undetectable HIV viral load.
Despite such advances, many shortfalls persist in regard to healthcare coverage for patients with HIV/AIDS. many individuals with HIV/AIDS—particularly those with low incomes—are still unable to access affordable, stable medical care, preventing them from receiving adequate therapy and increasing their risk for morbidity and mortality. In this educational activity, Jim Jorgenson, PharmD, and Jason Leider, MD, discuss a patient with HIV for whom a lapse in medical insurance led to increased viral load and other negative sequelae. The faculty review the patient’s clinical course of treatment, and provide their insights on how a team-based approached could have led to better care for this patient, and other patients with HIV who are navigating the managed health care system.
Managed care medical and pharmacy directors (primary audience); primary care clinicians (secondary audience); and all physicians and pharmacists
At the conclusion of this activity, participants should be better able to:
Describe evidence-based treatment goals for patients with HIV
Implement interventions to improve access to sustained, affordable care for patients with HIV
Conflict Of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, the University of Wisconsin-Madison, the Albert Einstein College of Medicine, and Haymarket Medical Education (HME) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.
Course Director Barry S. Zingman, MD Medical Director, AIDS Center Clinical Director, Infectious Diseases, Moses Division Montefiore Medical Center Professor of Clinical Medicine, Albert Einstein College of Medicine Bronx, NY
Dr. Zingman has nothing to disclose with regard to financial interests.
Course Reviewer Victor B. Hatcher, PhD Research Director Montefiore Medical Center Associate Dean Professor of Biochemistry and Medicine Albert Einstein College of Medicine Bronx, NY
Dr. Hatcher has nothing to disclose with regard to financial interests.
James Jorgenson, MS, RPh, FASHP President of Hospital & Health Systems Services Chief Operating Officer Visante, Inc. St. Paul, MN
Dr. Jorgenson is the CEO and is on the Board of Directors of Visante, Inc. and Visante Ltd. He also receives speaking fees from Impact Education, Janssen, Mallinckrodt, and Novartis.
Jason M. Leider, MD, PhD Professor of Clinical Medicine Department of Medicine Albert Einstein College of Medicine Bronx, NY
Dr. Leider receives consulting fees from Gilead and Merck and is also on the speakers’ bureau for Bristol-Meyers Squibb, Gilead, Janssen, and Merck.
Accredited Provider Disclosure
The staff of the Center for Continuing Medical Education of Albert Einstein College of Medicine has nothing to disclose with regard to commercial support.
The staff of the University of Wisconsin-Madison Interprofessional Continuing Education Partnership (ICEP) has nothing to disclose with regard to commercial support.
Publishing Staff Disclosures
Krista Sierra and Susan Basilico of Haymarket Medical Education have nothing to disclose with regard to commercial support.
AMA PRA Category 1 Credit(s)TM
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Albert Einstein College of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)TM . Physicians should only claim those credits commensurate with the extent of their participation in the activity.
CE for Pharmacists
In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
A total of 0.50 hours (0.05 CEUs) of pharmacy CE credit will be provided for successful completion of this knowledge-based program. To receive CE credit, you must complete the program; complete the evaluation; and complete the post-test with a minimum score of 70%. Verification of completion will be provided to NABP within 2 days of completion of this program. No credit will be provided 60 days after this program expires.
Universal Program #0073-9999-17-048-H02-P
Disclosure of Unlabeled Use
This CME activity will not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine, University of Wisconsin-Madison, Janssen Therapeutics, and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
To obtain credit, a score of 70% or better on the post-test is required. Please proceed until you have successfully completed this activity and completed the post-test and evaluation, and for CME credit only, that you have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.
For CPE credit, your credit will automatically be provided to NABP. Please verify that your credit has been recorded by checking your NABP profile after 2 business days.